Key result
ALBI score fails to identify early right ventricular dysfunction in repaired tetralogy of Fallot.
Why the study?
Does the ALBI score correlate with subclinical right ventricular dysfunction in pediatric patients after tetralogy of Fallot repair?
Cross-Sectional (n=92)
Does the ALBI score correlate with subclinical right ventricular dysfunction in pediatric patients after tetralogy of Fallot repair?
The ALBI score does not appear to be a useful biomarker for early, subclinical right ventricular dysfunction in stable pediatric patients after tetralogy of Fallot repair.
Answers are grounded in this paper and cite their sources.
Should not be used to detect early RV dysfunction in stable pediatric TOF; leaves open need for effective alternative biomarkers.
BACKGROUND: Right ventricular (RV) dysfunction is a key determinant of long-term morbidity in patients following surgical repair of tetralogy of Fallot (TOF). Identifying practical biomarkers for early detection of right-sided heart failure remains clinically relevant, particularly in pediatric populations with subclinical disease. The albumin-bilirubin (ALBI) score, a simple and objective marker of hepatic function, has emerged as a potential surrogate of systemic congestion in heart failure. This study aimed to evaluate whether the ALBI score reflects right ventricular dysfunction in pediatric patients after TOF repair and to examine its relationship with N-terminal pro-brain natriuretic peptide (NT-proBNP) and echocardiographic indices. METHODS: In this cross-sectional study, 46 pediatric patients (<8 years) with repaired TOF and 46 age-matched healthy controls were enrolled. Clinical data, laboratory parameters including ALBI score and NT-proBNP, and comprehensive echocardiographic measurements were obtained. Associations between ALBI score and demographic, biochemical, and imaging variables were analyzed. RESULTS: The median postoperative time since surgical repair was 99 months. Compared with controls, repaired TOF patients exhibited significantly elevated NT-proBNP levels (p < 0.001), increased RV and right atrial diameters (p < 0.001 and p = 0.017), and reduced tricuspid annular plane systolic excursion (p < 0.001), indicating subclinical RV dysfunction. However, the ALBI score did not differ between groups (p = 0.848) and showed no significant association with functional class, anti-congestive therapy, NT-proBNP levels, or echocardiographic parameters. CONCLUSION: Despite structural and biomarker evidence of subclinical RV involvement, the ALBI score did not reflect early right ventricular dysfunction in this relatively stable pediatric TOF cohort. Prospective studies including patients with more advanced hemodynamic impairment are warranted to clarify whether ALBI may have prognostic or monitoring value in later stages of right ventricular dysfunction.
No takes yet. Share an insight, caveat, or question.
Sönmez et al. (2026) conducted a cross-sectional in Tetralogy of Fallot (n=92). Repaired tetralogy of Fallot vs. Age-matched healthy controls was evaluated on ALBI score (p=0.848). The ALBI score did not differ between pediatric patients with repaired tetralogy of Fallot and healthy controls, failing to reflect early right ventricular dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: